Colorado Blood Cancer Institute, Lab — Denver, Colorado

Colorado Blood Cancer Institute, Lab is a clinical research site located in Denver, Colorado, United States 80218.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Colorado Blood Cancer Institute, Lab has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Myelodysplastic Syndrome, Acute Myeloid Leukemia.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Colorado Blood Cancer Institute, Lab?

Colorado Blood Cancer Institute, Lab has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Colorado Blood Cancer Institute, Lab conducted?

Colorado Blood Cancer Institute, Lab has 1 clinical trials on record, with 1 currently active. Their work covers Myelodysplastic Syndrome, Acute Myeloid Leukemia.

Is Colorado Blood Cancer Institute, Lab accredited by Crixeo Health?

Colorado Blood Cancer Institute, Lab has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Colorado Blood Cancer Institute, Lab?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.